Mesoblast
MESO
#4332
Rank
HK$18.79 B
Marketcap
HK$145.99
Share price
3.59%
Change (1 day)
73.11%
Change (1 year)

Mesoblast (MESO) - Cash on Hand

Cash on Hand as of June 2025 : HK$1.25 Billion

According to Mesoblast 's latest financial reports the company has HK$1.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mesoblast - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30HK$0.48 B-12.09%
2023-06-30HK$0.55 B17.96%
2022-06-30HK$0.47 B-55.53%
2021-06-30HK$1.05 B6.02%
2020-06-30HK$0.99 B155.78%
2019-06-30HK$0.39 B33.72%
2018-06-30HK$0.29 B384.58%
2017-06-30HK$60.28 M-64.46%
2016-06-30HK$0.16 B3.59%
2015-06-30HK$0.16 B452.09%
2014-06-30HK$29.65 M-51.44%
2013-06-30HK$61.07 M467.24%
2012-06-30HK$10.76 M-99.47%
2011-06-30HK$2.04 B720.66%
2010-06-30HK$0.24 B94.9%
2009-06-30HK$0.12 B16.54%
2008-06-30HK$0.10 B16.64%
2007-06-30HK$94.22 M54.44%
2006-06-30HK$61 M-47.98%
2005-06-30HK$0.11 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
HK$17.26 M-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
HK$1.02 M-99.92% Bahamas